Close Menu
    Facebook X (Twitter) Instagram
    SciTechDaily
    • Biology
    • Chemistry
    • Earth
    • Health
    • Physics
    • Science
    • Space
    • Technology
    Facebook X (Twitter) Pinterest YouTube RSS
    SciTechDaily
    Home»Health»Alzheimer’s Breakthrough: Researchers Find New Clues to Cognitive Decline in Healthy Adults
    Health

    Alzheimer’s Breakthrough: Researchers Find New Clues to Cognitive Decline in Healthy Adults

    By Mayo ClinicNovember 20, 2026No Comments4 Mins Read
    Facebook Twitter Pinterest Telegram LinkedIn WhatsApp Email Reddit
    Share
    Facebook Twitter LinkedIn Pinterest Telegram Email Reddit
    Old Man Alzheimer's Dementia
    Early detection of Alzheimer’s disease could help identify people at risk of cognitive decline years before symptoms appear. Advances in blood testing and biomarkers are bringing researchers closer to predicting future risk and developing strategies to delay or prevent memory loss. Credit: Stock

    Researchers have identified a promising way to assess Alzheimer’s-related cognitive risks in otherwise healthy older adults.

    A blood test could help estimate whether someone with no memory problems will develop cognitive impairment within the next five or 10 years. In a new Mayo Clinic study published in JAMA Neurology, researchers developed a method that combines an Alzheimer’s-related blood biomarker with age, sex, and genetic risk to produce personalized estimates.

    For example, a 75-year-old woman without the APOE e4 genetic risk variant had an estimated five-year risk of mild cognitive impairment (MCI) of 5% when her biomarker level was relatively low. At a higher level, that estimate rose to 16%. Her predicted 10-year risk increased from 12% to 35%.

    A Blood Test That Looks Beyond Alzheimer’s Biomarkers

    The method measures phosphorylated Tau 217 (p-tau217), a protein associated with Alzheimer’s disease. Elevated levels in the blood are linked to Alzheimer’s-related changes in the brain, but a positive biomarker result alone cannot determine whether or when someone will develop cognitive symptoms.

    “The goal is to provide a personalized estimate of the risk of developing cognitive impairment that is more meaningful than simply reporting whether a blood test is positive or negative for amyloid pathology,” says Alicia Algeciras-Schimnich, Ph.D., a Mayo Clinic laboratory medicine and pathology researcher and first author of the study.

    The research builds on an earlier Mayo Clinic prediction model that used positron emission tomography (PET) brain scans to detect amyloid, a protein that accumulates in the brains of people with Alzheimer’s disease. Measuring p-tau217 in blood offers a less invasive approach that could be used more widely.

    How Age and Blood Biomarkers Shape Future Risk

    Researchers analyzed data from 1,644 cognitively healthy participants in the Mayo Clinic Study of Aging and 534 participants in the Alzheimer’s Disease Neuroimaging Initiative. All were between 60 and 90 years old and had undergone blood biomarker measurements, genetic testing, and repeated cognitive assessments.

    Using the Mayo Clinic data, the team calculated the probability of developing MCI or dementia within five or 10 years. Higher p-tau217 levels and older age were associated with greater risk. At the same elevated biomarker level, the estimated five-year risk of MCI was 6% for a 65-year-old but 37% for an 85-year-old.

    The researchers then examined the Alzheimer’s Disease Neuroimaging Initiative data, which independently supported the association between elevated p-tau217 and increased risk of cognitive decline.

    Could Earlier Risk Estimates Guide Alzheimer’s Prevention?

    The approach could eventually help doctors identify people who might benefit from preventive treatment before memory problems begin. However, its clinical usefulness will depend partly on whether therapies can successfully delay cognitive decline in people who have no symptoms.

    “A person may want to know: What is my risk of developing cognitive impairment in the next five or 10 years, and how does this blood test change that risk?” says Ronald Petersen, M.D., Ph.D., a Mayo Clinic neurologist and director of the Mayo Clinic Study of Aging. “If preventive therapies prove effective, those numbers could become very important in treatment decisions.”

    Clinical trials, including AHEAD 3-45 and TRAILBLAZER-ALZ 3, are investigating whether treatments targeting amyloid can delay cognitive decline before symptoms develop. Both trials have used blood biomarkers to help identify participants, highlighting their potential role in earlier Alzheimer’s research.

    Why More Research Is Still Needed

    “Absolute risk gives the biomarker result clinical context,” says Clifford Jack Jr., M.D., a Mayo Clinic neuroradiologist and senior author of the study. “If preventive treatments become available, this kind of information could help patients and clinicians have more informed conversations about the potential benefits and risks of treatment.”

    The risk estimates were developed using the Mayo Clinic Study of Aging and require further evaluation in more diverse populations and with other p-tau217 blood tests. Although the findings support the potential of personalized risk prediction, Alzheimer’s biomarker testing is not currently recommended for people without cognitive symptoms.

    Reference: “Absolute Risk of Progression to Cognitive Impairment Based on Plasma Phosphorylated Tau 217, Age, Sex, and APOE ε4” by Alicia Algeciras-Schimnich, Mingzhao Hu, Stephen D. Weigand, et al., 16 November 2026, JAMA Neurology.
    DOI: 10.1001/jamaneurol.2026.4292

    Never miss a breakthrough: Join the SciTechDaily newsletter.
    Follow us on Google and Google News.

    Aging Alzheimer's Disease Biomarkers Brain Neurology
    Share. Facebook Twitter Pinterest LinkedIn Email Reddit

    Related Articles

    Scientists Discover Early Alzheimer’s Warning Sign Hiding in Routine Brain Scans

    This High-Fat Diet Could Be the Secret to Keeping Your Brain Young

    Scientists Discover Natural Compounds That Clear Alzheimer’s Proteins

    The Human Brain’s Fatal Flaw: A New Look at Alzheimer’s Origins

    New Blood Test Detects Alzheimer’s With Over 90% Accuracy

    Blood Test Predicts Dementia up to 10 Years in Advance, Study Finds

    New Anti-Aging Compounds Show Promise in Treating Alzheimer’s Disease

    USC Researchers Uncover Hidden “Brain Drain” Responsible for Vascular Dementia

    Beyond Traditional Targets: New Protein Research Shakes Up Alzheimer’s Treatments

    Leave A Reply Cancel Reply

    • Facebook
    • Twitter
    • Pinterest
    • YouTube

    Don't Miss a Discovery

    Subscribe for the Latest in Science & Tech!

    Trending News

    Stanford Scientists Discover 3 Hidden Brain Types in Children With ADHD and Anxiety

    What Is a Thought Made Of? Scientists Reveal Why Human Consciousness May Be Beyond the Reach of AI

    Scientists Discover Mysterious Toxic Chemicals Floating in the Air Above America

    Astronomers Discover a Chilling Preview of Our Solar System’s Future

    Scientists Discover Alarming Signs of Extinction Risk Deep Beneath the Ocean

    A Common Gut Antibody May Be the Key to Preventing Colon Cancer Before It Starts

    Scientists Discover a Disturbing Link Between Cannabis Use and Earlier Psychosis

    Scientists Discover Two Monster Black Holes at the Dawn of Time That Shouldn’t Exist

    Follow SciTechDaily
    • Facebook
    • Twitter
    • YouTube
    • Pinterest
    • Newsletter
    • RSS
    SciTech News
    • Biology News
    • Chemistry News
    • Earth News
    • Health News
    • Physics News
    • Science News
    • Space News
    • Technology News
    Recent Posts
    • Alzheimer’s Breakthrough: Researchers Find New Clues to Cognitive Decline in Healthy Adults
    • Heart Stents May Not Prevent Heart Attacks or Early Death, Landmark Study Finds
    • The Origins of Wealth Inequality May Go Back 5,000 Years, Ancient Graves Reveal
    • Why Did Early Humans Collect Strange Stones 500,000 Years Ago? Scientists Have a New Theory
    • On the Brink of Extinction, These Giant Sea Turtles Are Doing Something Unexpected
    Copyright © 1998 - 2026 SciTechDaily. All Rights Reserved.
    • Science News
    • About
    • Contact
    • Editorial Board
    • Privacy Policy
    • Terms of Use

    Type above and press Enter to search. Press Esc to cancel.